Verifying AXL and putative proteins as SARS‐CoV‐2 receptors by DnaE intein‐based rapid cell–cell fusion assay

Abstract

AbstractAs the understanding of the mechanisms of SARS‐CoV‐2 infection continues to grow, researchers have come to realize that ACE2 and TMPRSS2 receptors are not the only way for the virus to invade the host, and that there are many molecules that may serve as potential receptors or cofactors. The functionality of these numerous receptors, proposed by different research groups, demands a fast, simple, and accurate validation method. To address this issue, we here established a DnaE intein‐based cell‐cell fusion system, a key result of our study, which enables rapid simulation of SARS‐CoV‐2 host cell infection. This system allowed us to validate that proteins such as AXL function as SARS‐CoV‐2 spike protein receptors and synergize with ACE2 for cell invasion, and that proteins like NRP1 act as cofactors, facilitating ACE2‐mediated syncytium formation. Our results also suggest that mutations in the NTD of the SARS‐CoV‐2 Delta variant spike protein show a preferential selection for Spike‐AXL interaction over Spike‐LDLRAD3. In summary, our system serves as a crucial tool for the rapid and comprehensive verification of potential receptors, screening of SARS‐CoV‐2–neutralizing antibodies, or targeted drugs, bearing substantial implications for translational clinical applications.